559
Participants
Start Date
February 28, 2005
Primary Completion Date
October 31, 2007
Study Completion Date
December 31, 2007
Risperdal Consta
12.5, 25, 37.5 or 50mg intramuscular (IM) injection every 2 weeks
Placebo
Matching placebo intramuscular (IM) injection every 2 weeks
Little Rock
La Mesa
National City
Washington D.C.
Bradenton
Hialeah
Lake Charles
Towson
Clementon
Lyndhurst
Oklahoma City
Philadelphia
DeSoto
Richmond
Neunkirchen
Bangalore
Hyderabad
Manipal
Johor Bahru
Kota Bharu
Kuala Lumpur
Choroszcz
Gdansk
Swiecie Poland
Tuszyn
Lipetsk
Moscow
Moscow Region
Moscow Russia
Nizny Novgorod
Saint Petersburg
Samara
Saratov
St-Petresburg
Bratislava
Košice
Rimavská Sobota
Barcelona
Madrid
Taichung
Tainan City
Taipei
Taoyuan District
Dnipro
Hlevakha
Kharkiv
Kiev
Lviv
Odesa
Simferopol
Vinnitsa
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
INDUSTRY